CRL Global Services (Kansas), an independent clinical testing laboratory operation, has concluded a deal with Quotient Bioresearch (Cambridgeshire, UK) that will see CRL Global Services establish its new European laboratory hub in the UK.
CRL Global Services has chosen to construct its own laboratory in Cambridgeshire, UK, embedded within the existing facilities of Quotient Bioresearch. It will provide a further full service laboratory arm to CRL Global Services’ existing global structure. The contract also provides for an immediate close collaboration between the companies on the development and delivery of new services, particularly in the areas of bioanalysis, biomarkers, and microbiology.
David Griffiths, PhD MBA, business development director, Quotient Bioresearch, added: “We are very pleased to be working together with CRL Global Services as they construct their new laboratory in the UK. The established capabilities of the two companies are entirely complementary. I anticipate synergies that will enable us to deliver a joint offering significantly broader than available from each party working alone.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.